Jonathan Edwards
Senior Member (Voting Rights)
For me, despite individual inconsistencies in studies, I see a strong global pattern pointing specifically to impairment of OxPhos and concurrent upregulation of glycolysis, glutamine metabolism, and beta oxidation as compensatory mechanisms.
I agree that at least some studies suggest a diversion of metabolic pathways. But, like Mike Murphy (mitochondria, Cambridge, UK), I am sceptical that we have any evidence for inadequate ATP production. People who cannot generate ATP generally, as I end stage heart failure, or locally in muscle, as in late myositis or dystrophy, develop involuntary habits for minimising the impact of the deficit that are quite different from those I see in people with ME/CFS.
Disability in ME/CFS looks to me much more like a matter of inhibitory immune and/or neural signals shutting off usage of muscle or brain with a time course that does not look like any sort of ATP depletion.
Shift in pathway usage may be important clues to what the inhibitory signals are, of course.
As I have mentioned before, I am not very convinced by the importance of 'redox'. Again, I am not sure what it would explain to have redox imbalance.
I worry that a lot of ME/CFS research tries to find something that clinically we would not actually expect to find. 'Fatigue = not enough ATP' doesn't seem to me to be a good starting point.